Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLOG
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
The Stage-Gate Model: A Proven Approach to Streamline Biomanufacturing
As biopharma companies outsource more specialized activity to CDMOs, successful technology transfer becomes even more integral to project success. To...
Resilience builds lab supply chain tracking platform on AWS
by Adam Mendez, Alissa Gordon, and Lee Tessler Originally published on AWS | 27 NOV 2023 We would like to acknowledge the valuable contributions of...
On-demand Video: Efficiency Meets Economy: The Power of Single-Use Chromatography in mAb Purification
Read on
.jpeg)
How digital twins help improve biomanufacturing quality and security
Biomanufacturing safety and efficacy depend on well-controlled, compliant manufacturing processes. Can a virtual model truly give biomanufacturing...
On-demand Video: Idea to Clinic – Aim to Reduce your Manufacturing Timeline by ~30%
Are you an innovator company looking for a reliable and innovative partner? You have come to the right place.
Accelerating Clinical Timelines of Induced Pluripotent Stem Cells (iPSCs) with Pluristyx
Resilience and Pluristyx have entered a strategic collaboration to accelerate and simplify the transition of promising iPSC-derived therapies from...
